Group 1 - Suominen Corporation has entered into a EUR 50 million term loan and a EUR 50 million revolving credit facility agreement with a maturity of three years and a one-year extension option [1][2] - The new credit facility replaces the existing EUR 100 million syndicated revolving credit facility [2] - The lenders for the new facility are Danske Bank A/S and Nordea Bank Abp, and it includes leverage ratio and gearing as financial covenants [1] Group 2 - Suominen manufactures nonwovens for wipes and other applications, aiming to be a leader in nonwovens innovation and sustainability [3] - The company's net sales in 2024 were EUR 462.3 million, and it employs over 700 professionals in Europe and the Americas [3] - Suominen's shares are listed on Nasdaq Helsinki [3]

Charles Heaulme photo Charles Heaulme photo Suominen Corporation, inside information, June 30, 2025 at 4:20 p.m. EEST Suominen Corporation’s Board of Directors has appointed Mr. Charles Héaulmé, current Chair of the Board, as the company’s new President and CEO. Mr. Héaulmé will start at the latest August 11, 2025. Mr. Héaulmé brings with him decades of executive leadership experience across various industries. His strategic insight and proven track record in driving performance and transformation hav ...

近年来，日照市中医医院脑病科神经介入团队一直紧跟专业发展趋势，不断开展新技术、新项目，在颅内动脉瘤、颅内外动脉 狭窄、急诊取栓等方面取得了突出成绩。此次成功应用最小型号WEB支架治疗左侧大脑前动脉瘤，不仅彰显了团队在复杂、疑 难脑血管病诊疗方面的专业实力和技术水平，也展示了科室在运用新技术、新材料救治脑血管病患者方面的优异成果。 此次手术的成功，不仅为王大娘个人带来了福音，也为今后类似病例的治疗提供了宝贵的经验和参考。它标志着日照市中医医 院脑病科在脑血管病介入治疗领域迈出了坚实的一步。未来，日照市中医医院脑病科神经介入团队将继续秉承"以患者为中 心"的服务理念，不断探索和创新，为更多脑血管病患者带来福音。 (日照市中医医院) 近日，日照市中医医院传来喜讯，脑病科主任牟磊神经介入团队成功完成了山东省首例应用最小型号WEB支架治疗颅内动脉瘤 的手术，为患者带来了新的治疗希望。 据了解，患者王大娘来自五莲县，因左侧大脑前动脉A3段动脉瘤前往日照市中医医院就诊。面对这一复杂病例，脑病科神经介 入团队经过充分评估，决定采用国际先进的WEB支架进行治疗。经过手术，王大娘的病情得到了有效控制，术后效果良好。 WEB支架， ...

6月13日，欧盟委员会发布公告称，应Tech-Fab Europe于2025年3月12日提交的申请，对原产自中国和埃 及的玻璃纤维织物(Woven and/or Stitched Glass Fiber Fabrics)发起第一次反补贴日落复审调查，审查若取 消现行反补贴措施，涉案产品的补贴及该补贴对欧盟国内产业构成的损害是否将继续或再度发生。本次 日落复审倾销调查期为2024年1月1日～2024年12月31日，产业损害调查期为2021年1月1日至倾销调查期 结束。(中国贸易救济信息网) ...

Suominen Corporation's stock exchange release on June 16, 2025, at 4:00 p.m. EEST Jonni Friman, EVP, Transformation Management Office and a member of the Executive Management Team has decided to leave Suominen to pursue new opportunities outside the company. “I want to extend my heartfelt thanks to Jonni for his exceptional leadership of the Transformation Management Office (TMO). As planned, the TMO will now be dissolved, with its responsibilities seamlessly integrated into various functions to maintain ou ...

Suominen Corporation June 12, 2025 at 3:15 p.m. (EEST) Suominen Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Tommi BjörnmanPosition: Chief Executive Officer Issuer: Suominen OyjLEI: 743700Z1BNFYR9PRDF52Notification type: INITIAL NOTIFICATIONReference number: 110660/8/6 ____________________________________________Transaction date: 2025-06-11Outside a trading venueInstrument type: SHAREISIN: FI0009010862Nature of transaction: RECEI ...

The Bank of New York Mellon (BK) 2025 Conference June 11, 2025 02:30 PM ET Speaker0 For important disclosures, please see Morgan Stanley Research disclosure website at morganstanley.com/researchdisclosure. The taking of photographs and the use of recording devices is also not allowed. If you have any questions, please reach out to your Morgan Stanley sales representative. Okay. So thanks, everybody, for joining us this afternoon. We are pleased to have with us Jim Crowley, Global Head of BNY Pershing. Persh ...

Financial Data and Key Metrics Changes - The company reported a 2.7% growth in expenses for 2023, down from the previous two years of 8% growth, indicating improved cost management [30] - The company aims for mid-single-digit growth in net interest income (NII) for the year, reflecting a stable revenue trajectory [102] Business Line Data and Key Metrics Changes - The market and wealth services segment is the fastest growing and highest margin segment, contributing over half of the company's pretax income [38] - The investment and wealth management segment is focused on improving margins and has been challenged in revenue growth, with a target of returning to a 25% plus margin [47][96] - The security services segment is working on improving growth, with a focus on enhancing efficiency and reducing costs [41] Market Data and Key Metrics Changes - Approximately 40% of the company's revenues come from outside the US, highlighting its global market presence [7] - The company is positioned to benefit from active markets and increased trading activity, which are essential for its platform-based business model [5] Company Strategy and Development Direction - The company is undergoing a transformation to become more of a solutions provider, focusing on de-siloing operations and enhancing cross-selling opportunities [19][25] - The strategic pillars include being more client-focused, improving operational efficiency, and fostering a strong company culture [20][22] - The company is investing in AI and digital assets, anticipating significant benefits from these technologies in the coming years [33][88] Management's Comments on Operating Environment and Future Outlook - Management emphasized the importance of stability in the macroeconomic environment and its impact on client behavior, noting that their platforms are designed to operate effectively across various market conditions [11][53] - The company is optimistic about capturing megatrends in the market, particularly in private markets and digital assets, which are seen as growth opportunities [74][88] Other Important Information - The company has implemented a new commercial model to enhance sales processes and improve client engagement, which has already shown early positive results [24][34] - The focus on micro-innovations is expected to drive organic growth, with numerous small initiatives cumulatively adding significant value [70] Q&A Session Summary Question: What are the expectations for net interest income growth? - The company has guided for mid-single-digit growth in NII for the year, with an emphasis on stability and predictability in revenue generation [102] Question: How is the company addressing the challenges in the investment and wealth management segment? - New leadership has been brought in to focus on improving top-line results and distribution strategies, aiming to leverage existing capabilities more effectively [96][100] Question: What role does AI play in the company's future strategy? - AI is viewed as a transformative technology that will significantly impact corporate operations and is a key area of investment for the company [88]

Financial Data and Key Metrics Changes - Nordson's Q2 fiscal 2025 sales were $683 million, a 5% increase from $651 million in Q2 fiscal 2024, driven by an 8% increase from the Atrion acquisition, offset by a 2% organic sales decrease and less than 1% unfavorable currency translation [12][13] - Gross profit was $374 million, maintaining a consistent 55% of sales, with EBITDA adjusted for restructuring and integration costs at $217 million, or 32% of sales, reflecting a 7% increase year-over-year [12][13] - Net income totaled $112 million, or $1.97 per share on a GAAP basis, with adjusted earnings per share at $2.42, a 3% increase from the prior year [14] Business Line Data and Key Metrics Changes - Industrial Precision Solutions (IPS) sales decreased 8% to $319 million, with an EBITDA of $114 million, or 36% of sales, down 12% year-over-year due to lower sales volume [14][16] - Medical and Fluid Solutions sales increased 20% to $203 million, driven by the Atrion acquisition, with EBITDA of $77 million, or 38% of sales, a 22% increase from the prior year [17][18] - Advanced Technology Solutions (ATS) sales rose 18% to $161 million, with EBITDA of $40 million, or 25% of sales, a 43% increase year-over-year [19] Market Data and Key Metrics Changes - The company experienced solid order entry and backlog growth of 5% since the last quarter, particularly in electronics, precision agriculture, and select medical product lines [24] - The industrial systems segment showed sequential improvement compared to the first quarter, although automotive demand remains a headwind [38] Company Strategy and Development Direction - Nordson is focusing on divesting select product lines within its medical contract manufacturing business to concentrate on higher-value growth opportunities within the medical and fluid solutions segment [10] - The company is executing a balanced capital deployment strategy, including share repurchases totaling $85 million and $44 million in dividends, while maintaining a debt leverage ratio of 2.4 times [9][20] - The NBS Next framework is being utilized to assess the strategic fit of product lines and enhance operational efficiencies [10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in managing current tariff levels without significant impact on results, while monitoring potential effects on end market demand [22][93] - The outlook for Q3 fiscal 2025 sales is projected to be between $710 million and $750 million, with adjusted earnings forecasted between $2.55 and $2.75 per diluted share [27] - Management highlighted the resilience of Nordson's business model and its ability to adapt to market uncertainties, emphasizing ongoing investments in innovation and customer relationships [28][113] Other Important Information - The company reported a free cash flow generation of $103 million during the quarter, resulting in a 92% conversion rate on net income [20] - Nordson's integration of Atrion is performing above expectations, contributing positively to sales and margins [8][36] Q&A Session Summary Question: Trends for the rest of the year and major verticals - Management noted solid order entry in ATS, driven by investments in computing power, and expressed optimism about growth sustainability in the segment [34][35] Question: Size of contract manufacturing divestiture and future actions - The divestiture represents roughly 4% of year-to-date sales in the medical segment, with no other ongoing actions currently planned [43][44] Question: Consistency of growth in ATS segment - Management acknowledged the inherent volatility in ATS but indicated strong order entry patterns and confidence in organic growth [51][55] Question: Status of destocking in interventional medicine - Destocking is reducing in severity, with expectations for gradual recovery to normal demand growth rates [60][62] Question: Margin performance in ATS amid customer behavior volatility - Management indicated that while margins may fluctuate, structural changes have raised the baseline margin performance in the segment [68][69] Question: Impact of tariffs on financial performance - Current tariff levels are manageable, with minimal impact on Q2 results, and the company is monitoring potential effects on end market demand [90][93] Question: Growth drivers in ATS and semiconductor markets - Approximately 50% of ATS business is driven by semiconductor and high-performance computing, up from 20-30% a few years ago [96]

Company Actions - Suominen Corporation transferred 36,013 shares to the members of the Board of Directors as part of their remuneration, with 25% of the annual remuneration being paid in company shares [1] - After the transfer, Suominen holds a total of 496,103 treasury shares [1] Corporate Overview - Suominen manufactures nonwovens as roll goods for wipes and other applications, aiming to be a frontrunner in nonwovens innovation and sustainability [3] - The company's net sales in 2024 were EUR 462.3 million, and it employs over 700 professionals in Europe and the Americas [3] - Suominen's shares are listed on Nasdaq Helsinki [3]